Kursinformation
Aktuelle News
News Funktionen
Weitere Funktionen
25 Oktober 2023
ViGeneron GmbH
Nature Communications publication reveals highly efficient AAV delivery of large genes using ViGeneron´s REVeRT technology
22 August 2023
ViGeneron GmbH
ViGeneron announces EMA Approval of Clinical Trial Application for VG901, a gene therapy to treat Retinitis Pigmentosa
11 Oktober 2022
ViGeneron GmbH
ViGeneron presents preclinical data on intravitreal gene therapy of Stargardt disease at ESGCT
26 April 2022
ViGeneron GmbH
ViGeneron announces follow-on collaboration with Daiichi Sankyo to develop a novel gene therapy for prevalent eye diseases
6 April 2022
ViGeneron GmbH
ViGeneron signs gene therapy strategic collaboration and option agreement with Regeneron for one inherited retinal disease target
18 Januar 2021
ViGeneron GmbH
ViGeneron announces research collaboration with Daiichi Sankyo to evaluate vgAAV for novel ophthalmic gene therapy